Reduced α4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson DiseasePhilipp Meyer, Johannes Schwarz, Karl Strecker et al.|Archives of General Psychiatry|2009Cited by 156
Central noradrenaline transporter availability in highly obese, non-depressed individualsSwen Hesse, Osama Sabri, Michael Rullmann et al.|European Journal of Nuclear Medicine and Molecular Imaging|2017Cited by 110
Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporterKarl Strecker, Osama Sabri, Florian Wegner et al.|Journal of Neurology|2010Cited by 80
Altered serotonin transporter availability in patients with multiple sclerosisSwen Hesse, Osama Sabri, Franziska Moeller et al.|European Journal of Nuclear Medicine and Molecular Imaging|2014Cited by 67
The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive–compulsive disorderSwen Hesse, Osama Sabri, Katarina Stengler et al.|The International Journal of Neuropsychopharmacology|2011Cited by 62